Page last updated: 2024-09-03

dx 9065a and apixaban

dx 9065a has been researched along with apixaban in 2 studies

Compound Research Comparison

Studies
(dx 9065a)
Trials
(dx 9065a)
Recent Studies (post-2010)
(dx 9065a)
Studies
(apixaban)
Trials
(apixaban)
Recent Studies (post-2010) (apixaban)
92782,4052552,250

Protein Interaction Comparison

ProteinTaxonomydx 9065a (IC50)apixaban (IC50)
Coagulation factor XHomo sapiens (human)0.22

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doggrell, SA1
Arora, R; Chandrasekar, S; Loomba, R; Shah, P1

Reviews

2 review(s) available for dx 9065a and apixaban

ArticleYear
Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease?
    Reviews on recent clinical trials, 2011, Volume: 6, Issue:2

    Topics: Amidines; Coronary Artery Disease; Cyclic N-Oxides; Factor Xa; Factor Xa Inhibitors; Humans; Morpholines; Naphthalenes; Propionates; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes

2011
The need for novel anticoagulation therapy in acute coronary syndrome.
    American journal of therapeutics, 2013, Volume: 20, Issue:1

    Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Cyclic N-Oxides; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; Morpholines; Naphthalenes; Polysaccharides; Propionates; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Treatment Outcome; Warfarin

2013